Literature DB >> 33021556

The Value of DICER1 Mutation Analysis in "Subtle" Diagnostically Challenging Embryonal Rhabdomyosarcomas of the Uterine Cervix.

Ju-Yoon Yoon, Maria Apellaniz-Ruiz, Anne-Laure Chong, Zena Slim, Stuart G Salfinger, Blaise A Clarke, Colin J R Stewart, William D Foulkes, W Glenn McCluggage.   

Abstract

Embryonal rhabdomyosarcoma of the uterine cervix is a rare neoplasm which is almost invariably associated with pathogenic somatic or germline DICER1 mutations; patients with germline mutations have DICER1 syndrome. We report 2 subtle cervical embryonal rhabdomyosarcoma, one occurring in a 21-yr-old woman with a known history of DICER1 syndrome and the other in a 19-yr-old woman with no history of DICER1 syndrome or DICER1-associated neoplasms. Both neoplasms focally involved otherwise benign endocervical polyps and were characterized histologically by subtle areas of increased stromal cellularity, nuclear atypia and mitotic activity; there was focal nuclear staining of these areas with the skeletal muscle markers myogenin and myoD1. In both cases, demonstration of a somatic DICER1 RNase IIIb mutation in the tumor was instrumental in establishing the diagnosis. We believe these neoplasms represent the earliest discernible phase of cervical embryonal rhabdomyosarcoma. Pathologists should have a high index of suspicion when atypical stromal elements are present in endocervical polyps and immunohistochemistry together with DICER1 sequencing will assist in diagnosis.
Copyright © 2020 by the International Society of Gynecological Pathologists.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33021556     DOI: 10.1097/PGP.0000000000000718

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  1 in total

1.  Phenotypic similarities within the morphologic spectrum of DICER1-associated sarcomas and pleuropulmonary blastoma: Histopathologic features guide diagnosis in the LMIC setting.

Authors:  Paromita Roy; Anirban Das; Angad Singh; Joyshree Panda; Arpita Bhattacharya; Anisha Gehani; Mayur Parihar; Reghu K S; Rimpa Achari; Rita Alaggio; Amanda Field; D Ashley Hill; Louis P Dehner; Kris Ann P Schultz
Journal:  Pediatr Blood Cancer       Date:  2021-12-16       Impact factor: 3.838

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.